SCHEMBL18273045

SCHEMBL18273045

c1ccc(-n2c3ccccc3c3cc(-c4nc(-c5cccc(-n6c7ccccc7c7ccccc76)c5)c5sc6ccccc6c5n4)ccc32)cc1

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ATM Q13315 2/20 0.37
KDM4E B2RXH2 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
PTGER4 P35408 1/20 0.34
TNKS O95271 2/20 0.32
TNKS2 Q9H2K2 2/20 0.32
NPY5R Q15761 1/20 0.32
LIMK1 P53667 1/20 0.31
PIM1 P11309 1/20 0.31
PIM3 Q86V86 1/20 0.31
PIM2 Q9P1W9 1/20 0.31
MAPT P10636 2/20 0.30
ALDH1A1 P00352 2/20 0.30
LMNA P02545 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
RXFP1 Q9HBX9 1/20 0.30
MEN1 O00255 1/20 0.30
GAA P10253 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16905709 1.00 ATM (0.37) ATMKDM4EL3MBTL1PTGER4TNKS
SCHEMBL17030466 0.98 KDM4E (0.35) ATMKDM4EL3MBTL1PTGER4TNKS
SCHEMBL17087598 0.97 L3MBTL1 (0.36) ATMKDM4EL3MBTL1PTGER4TNKS
SCHEMBL16905913 0.96 ATM (0.40) ATMKDM4EL3MBTL1PTGER4TNKS
SCHEMBL18273052 0.95 KDM4E (0.36) ATMKDM4EL3MBTL1PTGER4TNKS
SCHEMBL16905693 0.95 KDM4E (0.36) ATMKDM4EL3MBTL1PTGER4TNKS
SCHEMBL22352557 0.95 LIMK1 (0.35) ATMKDM4EL3MBTL1PTGER4TNKS
SCHEMBL18273058 0.95 LIMK1 (0.35) ATMKDM4EL3MBTL1PTGER4TNKS
SCHEMBL18273047 0.95 LIMK1 (0.35) ATMKDM4EL3MBTL1PTGER4TNKS
SCHEMBL18273054 0.95 ATM (0.39) ATMKDM4EL3MBTL1PTGER4TNKS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160351826-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG SDI CO., LTD. (KR) 2016-12-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160351826-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 ATM 1355/4885KDM4E 3527/4885L3MBTL1 1170/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.